Vascular Diseases: all 1,036 studies

Page 10 of 11. Open to participants first (166), then studies with results posted, then the rest; newest registration first within each.

• Combination Stem Cell Therapy for the Treatment of Severe Leg IschemiaCompletedNCT00518401Phase 1
• A Non-Randomized Study of the NightHawk Peripheral Plaque Excision System During Plaque Excision of Peripheral Arterial DiseaseTerminatedNCT00516308Phase 2
• Study to Evaluate the Safety & Performance of the Xpert(TM) Stent in Treating Below-the-knee Lesions in Patients Undergoing Percutaneous Intervention for Chronic CLI.CompletedNCT00515346Phase 1
• Drug Eluting Stents In The Critically Ischemic Lower LegCompletedNCT00510393Phase 2
• Evaluating the Occurence of New and Progression of Existing Peripheral Venous Disease in Leg VeinsCompletedNCT00508079
• Plaque Removal Versus Open Bypass Surgery For Critical Limb IschemiaTerminatedNCT00504088Phase 4
• XIENCE V: SPIRIT WOMENCompletedNCT00496938Phase 4
• Belgian Prospective Multicentre Registry on the Performance of the Smart Stent in the Superficial Femoral Artery According to the New Tasc II-classificationCompletedNCT00496041Not applicable
• An Observational Registry Using Drug Eluting Stents (DES) in Patients in a Real-World Setting (DEScover Registry).CompletedNCT00489320
• To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT PatientsCompletedNCT00489229Phase 3
• Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery LesionsTerminatedNCT00489164Phase 1/2
• Sevelamer, Fetuin-A and Endothelial Dysfunction in CKDCompletedNCT00486772Phase 4
• Effect of Diet on Vascular Disease in Pre-Menopausal WomenCompletedNCT00484861
• Study of the SafeSeal(TM) Hemostasis Patch Following Percutaneous Coronary Artery and Peripheral Vascular InterventionsCompletedNCT00481741Phase 4
• A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent SystemCompletedNCT00475566Not applicable
• PTA and Drug Eluting Stents for Infrapopliteal Lesions in Critical Limb IschemiaStatus unknownNCT00471289Phase 2/3
• The Effect of a Diabetes Action Team in Patients Post Infrainguinal Bypass Surgery With and Without DiabetesTerminatedNCT00456105Not applicable
• Physical,Histological,and Genetic Analyses of Lipid-rich Atherosclerotic PlaquesStatus unknownNCT00449306
• Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST)CompletedNCT00442845Phase 4
• Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol TargetsCompletedNCT00442325Phase 4
• Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled TrialTerminatedNCT00437905Phase 4
• Autologous Bone Marrow Stem Cell Transplantation for Critical, Limb-threatening IschemiaStatus unknownNCT00434616Phase 2/3
• Effects of Cilostazol on VEGF and Oxidative Stress Biomarkers in Hemodialysis Patients With Peripheral Vascular DiseaseCompletedNCT00431249Phase 4
• Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)CompletedNCT00424710Phase 1
• Crossover Study With MultiHance vs a Comparator for Peripheral MRACompletedNCT00408083Phase 3
• Safety and Efficacy of Propionyl-L-Carnitine in the Treatment of Peripheral Arterial Disease (Intermittent Claudication)CompletedNCT00399919Phase 3
• ALD-301 for Critical Limb Ischemia, Randomized TrialCompletedNCT00392509Phase 1/2
• Cardiac Allograft Vasculopathy and Dobutamine Stress Echocardiography / Brain Natriuretic Peptide CouplingCompletedNCT00384540Not applicable
• Intravitreal Bevacizumab for Polypoidal Choroidal VasculopathyStatus unknownNCT00383812Not applicable
• Understanding the Genetic Basis of Atherosclerosis and Peripheral Arterial DiseaseCompletedNCT00380185
• Systematic Assessment of Vascular RiskCompletedNCT00378040
• Intra-arterial Stem Cell Therapy for Patients With Chronic Limb Ischemia (CLI)CompletedNCT00371371Phase 1/2
• Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous MaculopathyStatus unknownNCT00344617Phase 3
• Genomics of In-Stent RestenosisCompletedNCT00341562
• Home Blood Pressure-guided Antihypertensive Intervention for Elderly (HBP-GUIDE) StudyWithdrawnNCT00334724Phase 4
• Autologous Bone Marrow Cell Treatment in Peripheral AtherosclerosisStatus unknownNCT00306085Phase 1
• Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb IschemiaTerminatedNCT00300040Phase 2
• Atorvastatin Versus Ezetimibe and Fenofibrate as a Lipid-lowering StrategyCompletedNCT00299884
• Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery DiseaseCompletedNCT00296855Phase 3
• Effect of Atorvastatin (Lipitor) on Gene Expression in People With Vascular DiseaseCompletedNCT00293748
• L-Arginine in the Treatment of Peripheral Arterial DiseaseCompletedNCT00284076Not applicable
• Stem Cell Injection for Peripheral Vascular DiseaseCompletedNCT00278603Phase 1
• FIRE-PAD: Functional Improvement Through Revascularization of the Extremities for Peripheral Arterial DiseaseTerminatedNCT00274157
• Markers and Mechanisms of Vascular Disease in Type II DiabetesCompletedNCT00256646
• PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive PatientsStatus unknownNCT00251849Phase 3
• Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)TerminatedNCT00246493
• A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention ProgramCompletedNCT00236210Not applicable
• Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's DementiaStatus unknownNCT00229333Phase 4
• Oslo Balloon Angioplasty Versus Conservative TreatmentCompletedNCT00222196Not applicable
• Relation Between Renin-Angiotensin Gene Polymorphisms, Plasma Adiponectin and Arterial Stiffness in Renal Transplant RecipientsCompletedNCT00221533
• Stem Cell Study for Patients With Leg Ulcer/GangreneCompletedNCT00221143Phase 1/2
• Reducing Risk Factors in Peripheral Arterial DiseaseCompletedNCT00217919Not applicable
• Aldosterone and Vascular Disease in Diabetes MellitusCompletedNCT00214825Not applicable
• GORE-TEX PROPATEN Vascular Graft StudyCompletedNCT00205790Not applicable
• Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral ArteriesCompletedNCT00185276Phase 3
• ASSESS Study: Evaluation of ABSOLUTE™ Stent System for Occluded ArteriesCompletedNCT00180505Phase 4
• SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent SystemCompletedNCT00180453Phase 3
• The Burden of Peripheral Artery Occlusion Disease and Associated Factors in Peritoneal Dialysis PatientsStatus unknownNCT00173602
• Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With ClopidogrelCompletedNCT00163267Phase 2/3
• Evaluation of Fibrin Sealant 2 in Vascular Surgical ProceduresCompletedNCT00154141Phase 3
• Objective Evaluation of Proximal IschemiaCompletedNCT00152737
• Multicentric, Prospective, Randomized, Comparing Trial Between Bypass of the Femoropoplitea by PTFE and Heparin Bounded PTFECompletedNCT00147979Not applicable
• Blood Pressure and Glucose Lowering for the Prevention of Vascular Disease in High Risk Patients With Type 2 DiabetesCompletedNCT00145925Phase 3
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)Status unknownNCT00132743Phase 3
• Computerization of Medical Practices for the Enhancement of Therapeutic Effectiveness (COMPETE III)CompletedNCT00132145Not applicable
• Warfarin and Antiplatelet Vascular EvaluationStatus unknownNCT00125671Phase 3
• Rosiglitazone Plaque StudyStatus unknownNCT00123227Phase 3
• Safety and Efficacy Study of Ad2/Hypoxia Inducible Factor (HIF)-1α/VP16 Gene Transfer in Patients With Intermittent ClaudicationCompletedNCT00117650Phase 2
• Safety Study of Using Stem Cells to Stimulate Development of New Blood Vessels in Peripheral Vascular DiseaseStatus unknownNCT00113243Phase 1
• Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial DiseaseCompletedNCT00113009Phase 2
• The Effect of Folic Acid on Atherosclerosis, Cognitive Performance and HearingCompletedNCT00110604Not applicable
• Improving Functioning in Peripheral Arterial DiseaseCompletedNCT00106327Not applicable
• Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent ClaudicationCompletedNCT00102050Phase 2
• Safety/Efficacy of Everolimus and Neoral® in Adult Cardiac Transplant Patients With Established Allograft VasculopathyCompletedNCT00097968Phase 3
• Cholesterol Lowering Level of MK0653A+Simvastatin in Patients With Hypercholesterolemia and Atherosclerotic or Coronary Vascular Disease (0653A-806)(COMPLETED)CompletedNCT00090168Phase 3
• Alfimeprase for Thrombolysis in Acute Peripheral Arterial OcclusionCompletedNCT00073554Phase 2
• The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPICCompletedNCT00071266Phase 3
• Trial of VLTS-589 in Subjects With Intermittent ClaudicationCompletedNCT00068133Phase 2
• Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass GraftTerminatedNCT00067041Phase 2/3
• Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARICCompletedNCT00064545
• The Framingham Study: Examining DNA Markers and Links to DiseasesCompletedNCT00062777
• Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent ClaudicationCompletedNCT00062556Phase 3
• Study of Remodulin in Patients With Critical Limb Ischemia With No Planned Revascularization ProceduresTerminatedNCT00060996Phase 3
• Study of HGF Via Plasmid Vector to Improve Perfusion in Critical Limb IschemiaCompletedNCT00060892Phase 2
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial DiseaseCompletedNCT00059657Phase 3
• Efficacy/Safety of Ecraprost in Lipid Emulsion for Treatment of Critical Leg Ischemia Due to Peripheral Arterial DiseaseTerminatedNCT00059644Phase 3
• Prostaglandin E1 (Liprostin) Treatment With Lower Limb Angioplasty for Peripheral Arterial Occlusive DiseaseStatus unknownNCT00053716Phase 2
• Cardiac and Renal Disease Study (CARDS)CompletedNCT00049907
• Mechanisms of Disability in Peripheral Arterial DiseaseCompletedNCT00046592
• Prevention of Autogenous Vein Graft Failure in Peripheral Artery Bypass ProceduresCompletedNCT00041925Phase 2/3
• Epidemiology of Venous ThromboembolismCompletedNCT00041457
• Healthy Heart Amputation Rehabilitation Treatment (H.A.R.T)CompletedNCT00038285Phase 2
• Blood Factors and Peripheral Arterial Disease OutcomesCompletedNCT00035776
• Does the Reduction of Total Body Iron Storage (TBIS) Alter Mortality in a Population of Patients With Advanced PVD?CompletedNCT00032357Phase 3
• Extract of Ginkgo Biloba (EGB 761) and Vascular FunctionCompletedNCT00029991Phase 1/2
• Center for the Study of Vascular Disease in Hispanic and Native AmericansCompletedNCT00018590
• Epidemiology of Venous DiseaseCompletedNCT00005392
• Homocysteine and Progression of AtherosclerosisCompletedNCT00005338
• Natural History of Peripheral Arterial DiseaseCompletedNCT00005254
• Incidence of Diabetes and Cardiovascular Disease in Mexican AmericansCompletedNCT00005205

← Vascular Diseases overview